Non-responders to cardiac resynchronization therapy: the magnitude of the problem and the issues

Angelo Auricchio1, Frits W Prinzen

  • 1Division of Cardiology, Fondazione Cardiocentro Ticino, Via Tesserete 48, Lugano, Switzerland. angelo.auricchio@cardiocentro.org

Insights

Many patients do not benefit from cardiac resynchronization therapy (CRT). Identifying non-responders using risk stratification and clinical scores may improve patient selection for CRT.

Area of Science:

  • Cardiology
  • Medical Technology

Background:

  • A significant proportion of patients undergoing cardiac resynchronization therapy (CRT) do not respond to the treatment.
  • The increasing prevalence of heart failure necessitates improved patient selection for CRT to optimize resource allocation.

Purpose of the Study:

  • To discuss the definition and parameters of response to CRT.
  • To explore methods for predicting non-response to CRT.
  • To evaluate current strategies for patient selection and propose improvements.

Main Methods:

  • Review of existing literature on CRT response and non-response.
  • Analysis of parameters influencing CRT outcomes, including imaging and clinical data.
  • Discussion of the limitations of current patient selection methods.

Main Results:

  • Current methods for predicting CRT response have limitations.
  • Patient selection for CRT has not been optimized, leading to suboptimal resource utilization.
  • Mechanical dyssynchrony measures often face technical and interpretational challenges.

Conclusions:

  • Risk stratification incorporating left ventricular volumes, etiology, and QRS characteristics may better define non-responders than universal cut-off values.
  • Simple clinical scores could refine outcome prediction and improve daily practice measurement of CRT response.
  • Further research is needed to overcome technical limitations of imaging modalities for better patient selection.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...